Although long-term CD4+ T cell compartment depletion leads to obvious defects in both T and B cell adaptive immune responses, transient CD4+ T cell depletion has been clinically tested in cancer and other disease states using an ɑCD4 antibody. Here, CD4 is linked to cancer.